The fairest one-line summary is that DSIP appears to have real biological activity but a weak and inconsistent clinical efficacy signal
Read Full Article: #DiabetesResearch #CinnamomumZeylanicum #MetabolicHealth #Cardiometabolic #PreclinicalStudy #Phytotherapy To view or add a comment, sign in New research by investigators at the UAB Comprehensive Diabetes Center demonstrates that TIXiMED's oral compound, #TIX100, effectively prevents weight rebound following discontinuation of GLP-1 treatment in a mouse model of diet-induced obesity
however, pharmacokinetic interactions and safety considerations must be rigorously assessed
Most common side effect, typically resolves within hours
GLP-1 medications such as Ozempic, Wegovy, Mounjaro, and Zepbound have transformed weight management and type 2 diabetes care for millions of people
Start your weight loss journey today and schedule a complimentary weight loss consultation today